Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hartmann

Showing results (321-330 of 626) with videos related to

Pageof 63
Sort By:
European Journal of Medicinal Chemistry|March 5, 2014
Benzamidobenzoic acids as potent PqsD inhibitors for the treatment of Pseudomonas aeruginosa infectionsStefan Hinsberger, Johannes C de Jong, Matthias Groh, et al.
European Journal of Pediatrics|April 1, 1990
Serum immunoreactive erythropoietin of children in health and diseaseK U Eckardt, W Hartmann, U Vetter, et al.
ACS Chemical Biology|January 22, 2013
Peptide-based investigation of the Escherichia coli RNA polymerase σ(70):core interface as target siteKristina Hüsecken, Matthias Negri, Martina Fruth, et al.
Future Medicinal Chemistry|November 5, 2014
Surface plasmon resonance--more than a screening technology: insights in the binding mode of σ70:core RNAP inhibitorsKristina Hüsecken, Stefan Hinsberger, Walid A M Elgaher, et al.
Bioorganic Chemistry|October 16, 2012
Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroidsRanju Bansal, Sridhar Thota, Nalin Karkra, et al.
Biochemical and Biophysical Research Communications|July 11, 2016
Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesisSameer S Udhane, Bernhard Dick, Qingzhong Hu, et al.
Journal of Medicinal Chemistry|July 18, 2013
Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseasesMariano A E Pinto-Bazurco Mendieta, Qingzhong Hu, Matthias Engel, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1982
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compoundG Kranzfelder, R W Hartmann, E von Angerer, et al.
Journal of Medicinal Chemistry|June 9, 1995
Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 aromR W Hartmann, H Bayer, G Grün, et al.
European Journal of Medicinal Chemistry|September 28, 2011
Discovery of a new class of bicyclic substituted hydroxyphenylmethanones as 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitors for the treatment of osteoporosisMarie Wetzel, Emanuele M Gargano, Stefan Hinsberger, et al.
Pageof 63

Showing results (321-330 of 626) with videos related to

Sort By:
Pageof 63
European Journal of Medicinal Chemistry|March 5, 2014
Benzamidobenzoic acids as potent PqsD inhibitors for the treatment of Pseudomonas aeruginosa infectionsStefan Hinsberger, Johannes C de Jong, Matthias Groh, et al.
European Journal of Pediatrics|April 1, 1990
Serum immunoreactive erythropoietin of children in health and diseaseK U Eckardt, W Hartmann, U Vetter, et al.
ACS Chemical Biology|January 22, 2013
Peptide-based investigation of the Escherichia coli RNA polymerase σ(70):core interface as target siteKristina Hüsecken, Matthias Negri, Martina Fruth, et al.
Future Medicinal Chemistry|November 5, 2014
Surface plasmon resonance--more than a screening technology: insights in the binding mode of σ70:core RNAP inhibitorsKristina Hüsecken, Stefan Hinsberger, Walid A M Elgaher, et al.
Bioorganic Chemistry|October 16, 2012
Synthesis and aromatase inhibitory activity of some new 16E-arylidenosteroidsRanju Bansal, Sridhar Thota, Nalin Karkra, et al.
Biochemical and Biophysical Research Communications|July 11, 2016
Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesisSameer S Udhane, Bernhard Dick, Qingzhong Hu, et al.
Journal of Medicinal Chemistry|July 18, 2013
Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseasesMariano A E Pinto-Bazurco Mendieta, Qingzhong Hu, Matthias Engel, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1982
3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compoundG Kranzfelder, R W Hartmann, E von Angerer, et al.
Journal of Medicinal Chemistry|June 9, 1995
Pyridyl-substituted tetrahydrocyclopropa[a]naphthalenes: highly active and selective inhibitors of P450 aromR W Hartmann, H Bayer, G Grün, et al.
European Journal of Medicinal Chemistry|September 28, 2011
Discovery of a new class of bicyclic substituted hydroxyphenylmethanones as 17β-hydroxysteroid dehydrogenase type 2 (17β-HSD2) inhibitors for the treatment of osteoporosisMarie Wetzel, Emanuele M Gargano, Stefan Hinsberger, et al.
Pageof 63